Haemate®P/Humate-P®for the treatment of von Willebrand disease: considerations for use and clinical experience-Reference-Cited by-同舟云学术

Haemate®P/Humate-P®for the treatment of von Willebrand disease: considerations for use and clinical experience

Published:2008-11 Issue: Volume:14 Page:39-46
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

AUERSWALD G.,KREUZ W.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01850.x/fullpdf

Reference35 articles.

1. Von Willebrand disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment;Castaman;Haematologica,2003

2. Prevalence of von Willebrand disease in children: a multiethnic study;Werner;J Pediatr,1993

3. Impact, diagnosis and treatment of von Willebrand disease;Sadler;Thromb Haemost,2000

4. Health status and health-related quality of life associated with von Willebrand disease;Barr;Am J Hematol,2003

5. Advances in the therapy of von Willebrand disease;Battle;Haemophilia,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal design of infusion tests for the identification of physiological models of acquired von Willebrand syndrome;Chemical Engineering Science;2024-03

2. Inhibitors in Hemophilia A;Advances in Hemophilia Treatment;2022

3. Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients;Pediatric Critical Care Medicine;2019-10

4. Left ventricular assist devices and their complications: A review for emergency clinicians;The American Journal of Emergency Medicine;2019-08

5. Continuous-Flow Left Ventricular Assist Device–Related Gastrointestinal Bleeding;Cardiology Clinics;2018-11